Clinical Trial Detail

NCT ID NCT03834623
Title Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

melanoma

Therapies

CC-122 + Nivolumab

Age Groups: adult senior

No variant requirements are available.